Dclk1 Inhibition Cancels 5-FU-induced Cell-cycle Arrest and Decreases Cell Survival in Colorectal Cancer

Yuki Suehiro, Yoshihiro Takemoto, Arata Nishimoto, Koji Ueno, Bungo Shirasawa, Toshiki Tanaka, Naruji Kugimiya, Atsushi Suga, Eijiro Harada, Kimikazu Hamano

Anticancer Research · 2018 · 27 citations · 20 references

DOIFull text

Open access

Abstract

These results indicate that a combination of 5-FU and LRRK may be an effective, novel approach for colorectal cancer therapy.

References

20